AIAISci
中文
clinical updateBiotech

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Clinical/translation signal: Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Occurred SourceClinicalTrials.govapprovedSourceClinicalTrials.gov

Factual summary

What happened

ClinicalTrials.gov registry update for Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

SourceClinicalTrials.gov

Why it matters

Clinical trial registry updates are translation signals, not commercialization claims by themselves.

SourceClinicalTrials.gov

Limitations

ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.

SourceClinicalTrials.gov

Linked output

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumorsclinical trial

People

No reviewed person relationship is attached to this event.

Organizations

National Cancer Institute (NCI)

Topics

No reviewed topic relationship is attached to this event.

Problems

No reviewed problem relationship is attached to this event.

Relationship evidence

Timeline

  1. clinical updateDasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
    SourceClinicalTrials.gov